STAT3 and colitis: Meanwhile, the combination can reduce the release of pro-inflammatory cytokines by inhibiting the MAPK, NF-κB, and signal transducer and activator of transcription 3 (STAT3) signaling pathways in the DSS-induced colitis (217).